Comparison by optical coherence tomography of paclitaxel-Eluting stents With sirolimus-Eluting stents Implanted in one coronary artery in one procedure - 6-month follow-up

Circulation Journal

Volumn 74, Issue 5, 2010, Pages 903-908

  Miyoshi, Naoki ^a   Shite, Junya ^a   Shinke, Toshiro ^a   Otake, Hiromasa ^a   Tanino, Yusuke ^a   Ogasawara, Daisuke ^a   Sawada, Takahiro ^a   Kawamori, Hiroyuki ^a   Kato, Hiroki ^a   Yoshino, Naoki ^a   Kozuki, Amane ^a   Hirata, Ken Ichi ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Neointima; Optical coherence tomography; Paclitaxel eluting stent; Peri strut low intensity; Sirolimuseluting stent

Indexed keywords

PACLITAXEL; RAPAMYCIN;

AGED; ANGIOCARDIOGRAPHY; ARTERY INTIMA PROLIFERATION; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; DIAGNOSTIC VALUE; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HUMAN; IMPLANTATION; INTERMETHOD COMPARISON; MALE; OPTICAL COHERENCE TOMOGRAPHY; RANDOMIZED CONTROLLED TRIAL;

AGED; AGED, 80 AND OVER; ANTIBIOTICS, ANTINEOPLASTIC; CORONARY ANGIOGRAPHY; CORONARY VESSELS; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PACLITAXEL; SIROLIMUS; TOMOGRAPHY, OPTICAL COHERENCE; TUBULIN MODULATORS; TUNICA INTIMA;

EID: 77951723057     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-09-0690     Document Type: Article

References (38)

1. Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002; 346: 1773-1780.
2. Moses WJ, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003; 349: 1315-1323.
3. Simonton CA, Brodie B, Cheek B, Krainin F, Metzger C, Hermiller J, et al. Comparative clinical outcomes of paclitaxel- and sirolimuseluting stents: Results from a large prospective multicenter registry-- STENT Group. J Am Coll Cardiol 2007; 50: 1214-1222.
4. Maritsa A, Varani E, Balducelli M, Varbella F, Lettieri C, Uguccioni L, et al. Comparison of effectiveness and safety of sirolimus-eluting stents versus bare-metal stents in patients with diabetes mellitus (from the Italian Multicenter Randomized DESSERT Study). Am J Cardiol 2008; 101: 1560-1566.
5. Colombo A, Drzewiecki J, Banning A, Grube E, Hauptmann K, Silber S, et al. Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions. Circulation 2003; 108: 788-794.
6. Murdoch A, Saia F, Piovaccari G, Manari A, Aurier E, Benassi A, et al. Long-term safety and efficacy of drug-eluting stents two-year results of the REAL (REgistro AngiopLastiche dell'Emilia Romagna) Multicenter Registry. Circulation 2007; 115: 3181-3188.
7. Bose R, Gupta G, Grayburn PA, Laible EA, Kang MJ, Choi JW. Safety of drug-eluting stents in the coronary artery in ST-elevation myocardial infarction at a single high-volume medical center. Am J Cardiol 2007; 100: 949-952.
8. Kirtland AJ, Ellis SG, Dawkins KD, Colombo A, Grube E, Popma JJ, et al. Paclitaxel-eluting coronary stents in patients with diabetes mellitus: Pooled analysis from 5 randomized trials. J Am Coll Cardiol 2008; 51: 708-715.
9. Diemen J, Garcia-Garcia HM, Kukreja N, Imani F, de Jaegere PP, Sianos G, et al. The long-term value of sirolimus- and paclitaxeleluting stents over bare metal stents in patients with diabetes mellitus. Eur Heart J 2007; 28: 26-32.
10. Kuchulakanti PK, Chu WW, Torguson R, Ohlmann P, Rha SW, Clavijo LC, et al. Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel- eluting stents. Circulation 2006; 113: 1108-1113.
11. Jeremias A, Sylvia B, Bridges J, Kirtane AJ, Bigelow B, Pinto DS, et al. Stent thrombosis after successful sirolimus-eluting stent implantation. Circulation 2004; 109: 1930-1932.
12. Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005; 293: 2126-2130.
13. Finn AV, Kolodgie FD, Harnek J, Guerrero LJ, Acampado E, Tefera K, et al. Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus- or paclitaxeleluting stents. Circulation 2005; 112: 270-278.
14. McFadden EP, Stabile E, Regar E, Cheneau E, Ong AT, Kinnaird T, et al. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet 2004; 364: 1519-1521.
15. Stone GW, Moses JW, Ellis SG, Schofer J, Dawkins KD, Morice MC, et al. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med 2007; 356: 998-1008.
16. Iakovou I, Schmidt T, Ge L, Sangiorgi GM, Stankovic G, Airoldi F, et al. Angiographic patterns of restenosis after paclitaxel-eluting stent implantation. J Am Coll Cardiol 2005; 45: 805-806.
17. Jensen LO, Maeng M, Thayssen P, Christiansen EH, Hansen KN, Galloe A, et al. Neointimal hyperplasia after sirolimus-eluting and paclitaxel-eluting stent implantation in diabetic patients: The Randomized Diabetes and Drug-Eluting Stent (DiabeDES) Intravascular Ultrasound Trial. Eur Heart J 2008; 29: 2733-2741.
18. Lee JH, Kim HS, Lee SW, Park JH, Choi SW, Jeong JO, et al. Prospective randomized comparison of sirolimusversus paclitaxeleluting stents for the treatment of acute ST-elevation myocardial infarction: pROSIT trial. Catheter Cardiovasc Interv 2008; 72: 25-32.
19. Corbett SJ, Cosgrave J, Melzi G, Babic R, Biondi-Zoccai GG, Godino C, et al. Patterns of restenosis after drug-eluting stent implantation: Insights from a contemporary and comparative analysis of sirolimus- and paclitaxel-eluting stents. Eur Heart J 2006; 27: 2330-2337.
20. Colombo A, Orlic D, Stankovic G, Corvaja N, Spanos V, Montorfano M, et al. Preliminary observations regarding angiographic pattern of restenosis after rapamycin-eluting stent implantation. Circulation 2003; 107: 2178-2180.
21. Matsumoto D, Shite J, Shinke T, Otake H, Tanino Y, Ogasawara D, et al. Neointimal coverage of sirolimus-eluting stents at 6-month follow-up: Evaluated by optical coherence tomography. Eur Heart J 2007; 28: 961-967.
22. Katoh H, Shite J, Shinke T, Matsumoto D, Tanino Y, Ogasawara D, et al. Delayed neointimalization on sirolimus-eluting stents: 6- month and 12-month follow up by optical coherence tomography. Circ J 2009; 73: 1033-1037.
23. Sawada T, Shite J, Negi N, Shinke T, Tanino Y, Ogasawara D, et al. Factors that influence measurements and accurate evaluation of stent apposition by optical coherence tomography: Assessment using a phantom model. Circ J 2009; 73: 1841-1847.
24. Jang IK, Tearney GJ, MacNeill B, Takano M, Moselewski F, Iftima N, et al. In vivo characterization of coronary atherosclerotic plaque by use of optical coherence tomography. Circulation 2005; 111: 1551-1555.
25. Kume T, Akasaka T, Kawamoto T, Ogasawara Y, Watanabe N, Toyota E, et al. Assessment of coronary arterial thrombus by optical coherence tomography. Am J Cardiol 2006; 97: 1713-1717.
26. Otake H, Shite J, Ako J, Shinke T, Tanino Y, Ogasawara D, et al. Local determinants of thrombus formation following sirolimuseluting stent implantation assessed by optical coherence tomography. J Am Coll Cardiol Cardiovasc Interv 2009; 2: 459-466.
27. Hwang CW, Wu D, Edelman ER. Physiological transport force govern drug distribution for stent-based delivery. Circulation 2001; 104: 600-605.
28. Suzuki Y, Ikeno F, Yeung AC. Drug-eluting stent strut distribution: A comparison between Cypher and Taxus by optical coherence tomography. J Invasive Cardiol 2006; 18: 111-114.
29. Wessely R, Blaich B, BelAiba RS, Merl S, Görlach A, Kastrati A, et al. Comparative characterization of cellular and molecular antirestenotic profiles of paclitaxel and sirolimus: Implications for local drug delivery. Thromb Haemost 2007; 97: 1003-1012.
30. Farb A, Heller PF, Shroff S, Cheng L, Kolodgie FD, Carter AJ, et al. Pathological analysis of local delivery of paclitaxel a polymercoated stent. Circulation 2001; 104: 473-479.
31. Suzuki T, Kopia G, Hayashi S, Bailey LR, Llanos G, Wilensky R, et al. Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary model. Circulation 2001; 104: 1188-1193.
32. Murakami D, Takano M, Yamamoto M, Inami S, Ohba T, Seino Y, et al. Advanced neointimal growth is not associated with a low risk of in-stent thrombus: Optical coherence tomographic findings after first-generation drug-eluting stent implantation. Circ J 2009; 73: 1627-1634.
33. Farb A, Burke AP, Kolodgie FD, Virmani R. Pathological mechanisms of fatal late coronary stent thrombosis in humans. Circulation 2003; 108: 1701-1706.
34. Finn AV, Joner M, Nakazawa G, Kolodgie F, Newell J, John MC, et al. Pathological correlates of late drug-eluting stent thrombosis: Strut coverage as a marker of endothelialization. Circulation 2007; 115: 2435-2441.
35. Gonzalo N, Serruys PW, Okamura T, van Beusekom HM, Garcia- Garcia HM, van Soest G, et al. Optical coherence tomography patterns of stent restenosis. Am Heart J 2009; 158: 284-293.
36. Teramoto T, Ikeno F, Lyons J, Ootake H, Yeung AC. Black spot surrounding stent struts observed by optical coherence tomography; what do these represent? Am Coll Cardiol 2009; 53: A90-A90.
37. Lüscher TF, Steffel J, Eberli FR, Joner M, Nakazawa G, Tanner FC, et al. Drug-eluting stent and coronary thrombosis: Biological mechanisms and clinical implications. Circulation 2007; 115: 1051-1058.
38. Smith EJ, Rothman MT. Antiproliferative coatings for the treatment of coronary heart disease: What are the targets and which are the tools? J Interv Cardiol 2003; 16: 475-483.